PDA

View Full Version : Resveratrol


Pages : [1] 2 3 4 5

  1. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin.
  2. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: Inhibition of ribonucleotide reductase activity.
  3. Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.
  4. Phytochemicals and regulation of the adipocyte life cycle.
  5. Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation.
  6. Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells.
  7. Antioxidant Protection of Resveratrol and Catechin in Saccharomyces cerevisiae.
  8. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
  9. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain.
  10. Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells.
  11. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.
  12. Vitisin A inhibits adipocyte differentiation through cell cycle arrest in 3T3-L1 cells.
  13. Lipoxygenase inhibitory constituents from rhubarb.
  14. Identification of Bacterial Carotenoid Cleavage Dioxygenase Homologues That Cleave the Interphenyl alpha,beta Double Bond of Stilbene Derivatives via a Monooxygenase Reaction.
  15. Dietary antioxidants as potential pharmacological agents for ischemic stroke.
  16. Determination of phenolic compounds in Yucca gloriosa bark and root by LC-MS/MS.
  17. Resveratrol improves non-alcoholic fatty liver disease by activating AMPactivated protein kinase.
  18. Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: Implications for colon cancer prevention.
  19. Resveratrol: an original mechanism on tyrosinase inhibition.
  20. Phytochemical composition of nuts.
  21. Induction of Apoptosis in Jeko-1 Mantle Cell Lymphoma Cell Line by Resveratrol: A Proteomic Analysis.
  22. [Effect of resveratrol on chronic obstructive pulmonary disease in rats and its mechanism]
  23. Silencing metabolic disorders by novel SIRT1 activators.
  24. In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs.
  25. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-{kappa}B activation in oesophageal cells, with a mechanism of action involving ROS.
  26. Cloning and functional characterization of BcatrA, a gene encoding an ABC transporter of the plant pathogenic fungus Botryotinia fuckeliana (Botrytis cinerea).
  27. Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships.
  28. [Effects of garlic oil combined with resveratrol on inducting of apoptosis and expression of Fas, bcl-2 and bax in human gastric cancer cell line]
  29. Efficient Synthesis and Neuroprotective Effect of Substituted 1,3-Diphenyl-2-propen-1-ones.
  30. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice.
  31. Resveratrol Induces Apoptosis through ROS-Dependent Mitochondria Pathway in HT-29 Human Colorectal Carcinoma Cells.
  32. Wine, Spirits and the Lung: Good, Bad or Indifferent?
  33. Red wine interferes with oestrogen signalling in rat hippocampus.
  34. Study of vacuum microwave-assisted extraction of polyphenolic compounds and pigment from Chinese herbs.
  35. Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications.
  36. Resveratrol and ischemic preconditioning in the brain.
  37. Mechanisms of Cancer Chemopreventive Agents: A Perspective.
  38. Comparison of the Phytohormones Genistein, Resveratrol and 8-Prenylnaringenin as Agents for Preventing Osteoporosis.
  39. [Studies on chemical constituents from roots of Caragana sinica]
  40. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
  41. [Inhibitory effect of resveratrol on cardiac fibroblast proliferation induced by angiotensin II]
  42. Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis.
  43. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives.
  44. Quality evaluation of Rhizoma Belamcandae (Belamcanda chinensis (L.) DC.) by using high-performance liquid chromatography coupled with diode array detector and mass spectrometry.
  45. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia.
  46. Curcumin and resveratrol inhibit Nuclear Factor-kappaB-mediated cytokine expression in adipocytes.
  47. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.
  48. Waldenstrom Macroglobulinemia.
  49. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women.
  50. Quantification of polyphenols with potential antioxidant properties in wines using reverse phase HPLC.
  51. Signal amplification by conjugate addition for differential sensing with synthetic pores.
  52. SIRT1 Promotes Differentiation of Normal Human Keratinocytes.
  53. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
  54. Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila.
  55. Trans-resveratrol inhibits early blood vessel formation (vasculogenesis) without impairment of embryonic growth.
  56. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
  57. Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
  58. The early expressed HIV-1 genes regulate DNMT1 expression.
  59. Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B.
  60. Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B.
  61. Sirtuins: Novel targets for metabolic disease in drug development.
  62. Antimalarial activity in mice of resveratrol derivative from Pleuropterus ciliinervis.
  63. ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells.
  64. Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2.
  65. Spinal nerve ligation reduces nitric oxide synthase activity and expression: Effect of resveratrol.
  66. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms.
  67. Differential Effects of Resveratrol on Androgen-responsive LNCaP Human Prostate Cancer Cells In Vitro and In Vivo.
  68. Synthesis and biological evaluation of cytotoxic properties of stilbene-based resveratrol analogs.
  69. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
  70. Insights into the pharmacological potential of estrogens and phytoestrogens on catecholamine signaling.
  71. Chain-breaking activity of resveratrol and piceatannol in a linoleate micellar model.
  72. Effect of flavonoids on rat splenocytes, a structure-activity relationship study.
  73. High-performance liquid chromatographic analysis of resveratrol analog 3,5,4'-trimethoxystilbene in rat plasma.
  74. A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells.
  75. Sirt1 protects against high-fat diet-induced metabolic damage.
  76. Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span.
  77. The Effects of Dietary Phenolic Compounds on Cytokine and Antioxidant Production by A549 Cells.
  78. Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.
  79. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.
  80. The convenient synthesis and evaluation of the anticancer activities of new resveratrol derivatives.
  81. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model.
  82. In vitro antiviral activity of resveratrol against respiratory viruses.
  83. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: Potential for use as a novel nutraceutical for the treatment of osteoarthritis.
  84. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.
  85. Localization of stilbene synthase in Vitis vinifera L. during berry development.
  86. Resveratrol protects primary rat hepatocytes against oxidative stress damage Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes.
  87. Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging.
  88. Inhibition of Acrylamide Toxicity in Mice by Three Dietary Constituents.
  89. Kaempferol, but not resveratrol inhibits angiotensin converting enzyme.
  90. Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity.
  91. The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol.
  92. Diet, autophagy, and cancer: a review.
  93. Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses.
  94. Study of resveratrol and antioxidant activity in georgian brand red wines and a number of foreign red wines.
  95. Optimization of Solid-Liquid Extraction of Resveratrol and Other Phenolic Compounds from Milled Grape Canes (Vitis vinifera).
  96. Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane.
  97. Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion.
  98. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.
  99. Analysis of selected stilbenes in Polygonum cuspidatum by HPLC coupled with CoulArray detection.
  100. Resveratrol modulates innate and inflammatory responses in fish leucocytes.
  101. Targeting the mitochondria to augment myocardial protection.
  102. Sparsely Ionizing Diagnostic and Natural Background Radiations are Likely Preventing Cancer and Other Genomic-Instability-Associated Diseases.
  103. Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals.
  104. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.
  105. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited.
  106. Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent.
  107. Protection of human colon epithelial cells against deoxycholate by rottlerin.
  108. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart.
  109. Selective Growth Inhibition of Human Leukemia and Human Lymphoblastoid Cells by Resveratrol via Cell Cycle Arrest and Apoptosis Induction.
  110. The effect of long-term resveratrol treatment on relaxation to estrogen in aortae from male and female rats: Role of nitric oxide and superoxide.
  111. Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.
  112. Mitochondrial biogenesis and healthy aging.
  113. Grapes and Human Health: A Perspective.
  114. Microinjection of resveratrol into rostral ventrolateral medulla decreases sympathetic vasomotor tone through nitric oxide and intracellular Ca2+ in anesthetized male rats.
  115. [Suppressive effect in vitro of resveratrol on ADP induced human platelet aggregation and its active mechanism]
  116. Phytochemicals and age-related eye diseases.
  117. Potential of resveratrol in anticancer and anti-inflammatory therapy.
  118. Pharmacometrics of stilbenes: seguing towards the clinic.
  119. NEGATIVE REGULATION OF QUINONE REDUCTASE 2 BY RESVERATROL IN CULTURED VASCULAR SMOOTH MUSCLE CELLS.
  120. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
  121. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats.
  122. Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1alpha expression in colon carcinoma cells.
  123. Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species.
  124. Efficient Calculation of Molecular Properties from Simulation Using Kernel Molecular Dynamics.
  125. Growth inhibition of human colon cancer cells by plant compounds.
  126. Microwave-assisted aqueous two-phase extraction of piceid, resveratrol and emodin from Polygonum cuspidatum by ethanol/ammonium sulphate systems.
  127. DISSECTING THE SIGNALLING PATHWAYS INVOLVED IN THEANTI-HYPERTROPHIC EFFECTS OF RESVERATROL.
  128. SIRT1 confers protection against UVB- and H(2)O(2)-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes.
  129. Effect of melatonin, curcumin, quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe-NTA)-induced renal oxidative damage in rats.
  130. Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases.
  131. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes.
  132. Potential Food Additives from Carex distachya Roots: Identification and in Vitro Antioxidant Properties.
  133. Resveratrol in prevention and treatment of common clinical conditions of aging.
  134. Enhanced Tolerance against Early and Late Apoptotic Oxidative Stress in Mammalian Neurons through Nicotinamidase and Sirtuin Mediated Pathways.
  135. Trans-resveratrol: a magical elixir of eternal youth?
  136. Analysis of trans-Resveratrol in Grapes by Micro-High Performance Liquid Chromatography.
  137. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial g
  138. The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols.
  139. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha.
  140. Aggregation State and pKa Values of (E)-Resveratrol As Determined by Fluorescence Spectroscopy and UV-Visible Absorption.
  141. Cross-talk between Aryl Hydrocarbon Receptor and Mitogen-Activated Protein Kinase Signaling Pathway in Liver Cancer through c-raf Transcriptional Regulation.
  142. Resveratrol reestablishes spermatogenesis after testicular injury in rats caused by 2, 5-hexanedione.
  143. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms.
  144. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production.
  145. Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis.
  146. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells.
  147. [Regulatory Effect of Resveratrol on JAK1/STAT3 Signal Transduction Pathway in Leukemia.]
  148. Inhibitory effects of genistein and resveratrol on guinea pig gallbladder contractility in vitro.
  149. Resveratrol Alleviates Alcoholic Fatty Liver in Mice.
  150. Protective effect of resveratrol in endotoxemia-induced acute phase response in rats.
  151. [Resveratrol improves high-fat induced nonalcoholic fatty liver in rats.]
  152. A High Throughput Live Transparent Animal Bioassay to Identify Non-toxic Small Molecules or Genes that Regulate Vertebrate Fat Metabolism for Obesity Drug Development.
  153. Activation of Sirt1 Decreases Adipocyte Formation during Osteoblast Differentiation of Mesenchymal Stem Cells.
  154. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
  155. Survey of the trans-Resveratrol and trans-Piceid Content of Cocoa-Containing and Chocolate Products.
  156. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production.
  157. Steroidal Saponins from the Roots of Smilax aspera subsp. mauritanica.
  158. Prokaryotic expression, polyclonal antibody preparation of the stilbene synthase gene from grape berry and its different expression in fruit development and under heat acclimation.
  159. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.
  160. trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation.
  161. Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol.
  162. Influence of Phenolic Constituents from Yucca schidigera Bark on Arachidonate Metabolism in Vitro.
  163. Resveratrol, a new biomarker of moderate wine intake?
  164. Resveratrol inhibits nonalcoholic fatty liver disease in rats.
  165. Chemopreventive Potential of Resveratrol in Mouse Skin Tumors Through Regulation of Mitochondrial and PI3K/AKT Signaling Pathways.
  166. Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress.
  167. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose.
  168. Sirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol.
  169. Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77).
  170. Selective On-Line Extraction of Trans-Resveratrol and Emodin from Polygonum cuspidatum Using Molecularly Imprinted Polymer.
  171. A Stress-Inducible Resveratrol O-Methyltransferases Involved in the Biosynthesis of Pterostilbene in Grapevine.
  172. An NF-kB-sensitive microRNA-146a-mediated inflammatory circuit in Alzheimer's disease and in stressed human brain cells.
  173. Benzanilides with spasmolytic activity: chemistry, pharmacology, and SAR.
  174. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line.
  175. RA Rapid and Sensitive Screening System for Human Type I Collagen with the Aim of Discovering Potent Anti-Aging or Anti-Fibrotic Compounds.
  176. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C.
  177. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
  178. Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: Involvement of inducible nitric oxide synthase and hemoxygenase-1.
  179. Pro-survival effects of repetitive low-grade oxidative stress are inhibited by simultaneous exposure to Resveratrol.
  180. Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: Prolonged effect related to COX-2 expression impairment.
  181. A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol.
  182. Does White Wine Qualify for French Paradox? Comparison of the Cardioprotective Effects of Red and White Wines and Their Constituents: Resveratrol, Tyrosol, and Hydroxytyrosol.
  183. [Protective effect of resveratrol on the intestinal mucosal cells in rats with severe acute pancreatitis and the mechanism.]
  184. Inhibitory effect of a novel resveratrol derivative on nitric oxide production in lipopolysaccharide-activated microglia.
  185. TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells.
  186. Inhibition of transcriptional activity of c-JUN by SIRT1.
  187. Development of mitochondria-targeted derivatives of resveratrol.
  188. Dietary trans-resveratrol bioavailability and effect on CCl-induced liver lipid peroxidation.
  189. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
  190. Akt/FOXO3a/SIRT1-Mediated Cardioprotection by n-Tyrosol against Ischemic Stress in Rat in Vivo Model of Myocardial Infarction: Switching Gears toward Survival and Longevity.
  191. [The mechanism of resveratrol on anti-hepatoma Bel-7402 and modulating IL-8 in tumor model mice]
  192. Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice.
  193. Sulforaphane targets pancreatic tumor-initiating cells by NF-{kappa}B-induced anti-apoptotic signaling.
  194. Resveratrol protects auditory hair cells from gentamicin toxicity.
  195. Novel mammalian cell lines expressing reporter genes for the detection of environmental chemicals activating endogenous aryl hydrocarbon receptors (ArhR) or estrogen receptors (ER).
  196. Resveratrol protects against oxidative injury induced by H(2)O(2) in acute hippocampal slice preparations from Wistar rats.
  197. Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice.
  198. [Study of anti-oxidant phenolic compounds from stem barks of Morus yunanensis]
  199. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
  200. SirT1 gain of function increases energy efficiency and prevents diabetes in mice.
  201. Biological/Chemopreventive Activity of Stilbenes and their Effect on Colon Cancer.
  202. Ultraviolet-C and Induced Stilbenes Control Ochratoxigenic Aspergillus in Grapes.
  203. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells.
  204. Nutrition, sirtuins and aging.
  205. trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways.
  206. Non-canonical autophagy: An exception or an underestimated form of autophagy?
  207. Effect of frequency and duration of ultrasonication on the extraction efficiency of selected isoflavones and trans-resveratrol from peanuts (Arachis hypogaea).
  208. The role of surface receptor stimulation on the cytotoxicity of resveratrol to macrophages.
  209. Targeted Isolation and Structure Elucidation of Stilbene Glycosides from the Bark of Lysidice brevicalyx Wei Guided by Biological and Chemical Screening.
  210. Resveratrol Attenuates Ventricular Arrhythmias and Improves the Long-Term Survival in Rats with Myocardial Infarction.
  211. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis.
  212. Sirt1 increases skeletal muscle precursor cell proliferation.
  213. Opposite effects of two resveratrol tetramers, vitisin A and hopeaphenol on apoptosis of myocytes isolated from adult rat heart.
  214. NF-kappaB in liver diseases: a target for drug therapy.
  215. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet.
  216. The potential value of natural antioxidative treatment in glaucoma.
  217. [Relationship between Apoptotic Effect of Resveratrol on KG-1 Cells and Expression of bcl-2/bax.]
  218. Opposite Effects of Metabolic Syndrome and Calorie Restriction on Thrombotic Disease: Head and Tail of Same Coin-Resveratrol's Role.
  219. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
  220. Resveratrol Oxidation in Botrytis cinerea Conidia.
  221. Botrytis cinerea Infection in Grape Flowers: Defense Reaction, Latency, and Disease Expression.
  222. Correlations of Morphological, Anatomical, and Chemical Features of Grape Berries with Resistance to Botrytis cinerea.
  223. Chitosan Oligomers and Copper Sulfate Induce Grapevine Defense Reactions and Resistance to Gray Mold and Downy Mildew.
  224. Cardioprotective and Antiarrhythmic Effects of Resveratrol-a Modern Perspective on an Old Treatment : Editorial to "Resveratrol Attenuates Ventricular Arrhythmias and Improves the Long-term Survival i
  225. The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues.
  226. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.
  227. Resveratrol regulates the expression of NHE-1 by repressing its promoter activity: Critical involvement of intracellular H(2)O(2) and caspases 3 and 6 in the absence of cell death.
  228. Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of -Thalassemia and Sickle-Cell Anemia.
  229. Resveratrol protects bone marrow mesenchymal stem cell derived chondrocytes cultured on chitosan-gelatin scaffolds from the inhibitory effect of interleukin-1beta.
  230. Cellular and Behavioral Effects of Stilbene Resveratrol Analogues: Implications for Reducing the Deleterious Effects of Aging.
  231. Study of phenolic compounds as natural antioxidants by a fluorescence method.
  232. Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera and determination by HPLC.
  233. Crystal and Molecular Structure of Piceatannol; Scavenging Features of Resveratrol and Piceatannol on Hydroxyl and Peroxyl Radicals and Docking with Transthyretin.
  234. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.
  235. Polyphenolic composition of roots and petioles of Rheum rhaponticum L.
  236. Resveratrol ameliorates hepatic injury via the mitochondrial pathway in rats with severe acute pancreatitis.
  237. A theoretical antioxidant pharmacophore for resveratrol.
  238. Direct determination of polydatin and its metabolite in rat excrement samples by high-performance liquid chromatography.
  239. Collisionally induced fragmentation of [M-H](-) species of resveratrol and piceatannol investigated by deuterium labelling and accurate mass measurements.
  240. LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
  241. Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells.
  242. Structure-Activity Relationship and Mechanism of the Tocopherol-Regenerating Activity of Resveratrol and Its Analogues.
  243. Induction of cytochromes P450 in small intestine by chemopreventive compounds.
  244. Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene.
  245. Resveratrol Regulates Circadian Clock Genes in Rat-1 Fibroblast Cells.
  246. Porcine Sirt1 gene clone, expression pattern, and regulation by resveratrol.
  247. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells.
  248. Regio- and Stereoselective Biomimetic Synthesis of Oligostilbenoid Dimers from Resveratrol Analogues: Influence of the Solvent, Oxidant, and Substitution.
  249. Restoration by Prostaglandins E(2) and F (2) (alpha) of Resveratrol-Induced Suppression of Hepatoma Cell Invasion in Culture.
  250. Effect of food on the pharmacokinetic profile of trans-resveratrol.